No Detail Found!

Pharmacokinetic and pharmacodynamic correlation of plasma concentrations and blood pressure in hypertensive patients: A study

Author(s)
Mahvash Iram Department of Pharmacy Practice, Al‐Ameen College of Pharmacy, Bengaluru, Karnataka, India
Shobha Rani Department of Pharmacy Practice, Al‐Ameen College of Pharmacy, Bengaluru, Karnataka, India
Nalini Pais Department of Medicine, St. Martha's Hospital, Bengaluru, Karnataka, India
Abstract
Objective: The aim of this study was to determine the correlation between the pharmacokinetic (PK) parameter (plasma concentration) and pharmacodynamic (PD) parameter (blood pressure [BP]) in hypertensive patients on metoprolol therapy. Materials and Methods: High-performance liquid chromatography (HPLC) method for the measurement of plasma concentrations was developed and validated, following which the Ethical Committee approval was obtained. Patients admitted with hypertension and above 18 years of age were randomized into two groups based on the time of administration of metoprolol. Patients for whom metoprolol therapy was contraindicated were excluded from the study. Results: One hundred and six patients were enrolled in the study; patients with 61-70 years formed majority, 51.8% of males were associated with hypertension compared to 48.2% of the females. Patients receiving morning dose of the drug showed higher plasma concentrations in comparison with evening dose. PK and PD correlation was carried out and correlation coefficient “R2” was calculated by the formula y = mx + c. For systolic BP of morning administration, R2 for peak concentration was found to be 0.913 and R2 for trough concentration was found to be 0.903. R2 value for diastolic BP of morning administration was found to be 0.873 for peak concentration and 0.969 for trough concentration. Systolic BP of evening exhibited R2 value of 0.986 and 0.955 for peak and trough concentrations, respectively. Diastolic BP of evening showed R2 value of 0.931 and 0.896 for peak and trough concentrations. Statistical analysis was done using Pearson's correlation test, and it was observed that there is a significant correlation (P < 0.001) between the plasma concentrations and BP. Conclusion: The PK and PD parameters are at par with each other. It can be concluded that there is a significant correlation between the BP and plasma concentrations. This can be considered as the preliminary finding to ascertain the various PK parameters to optimize the dosing schedule for hypertensive patients.
Publication Details
Page(s) 113-119
Published Journal: Archives of Pharmacy Practice, Volume: 7, Issue: 4, Year: 2016

Request the full text from PASTIC

Keywords
Pharmacokinetics, Metoprolol, Hypertension, pharmacodynamics
References
Litinski M,Scheer FA,Shea SA .2009 .Influence of the circadian system on disease severity. Sleep Med Clin, 4 : 143-63.
Reddy AB,O'Neill JS .2010 .Healthy clocks, healthy body, healthy mind. Trends Cell Biol, 20 : 36-44.
Kario K,White WB .2008 .Early morning hypertension: What does it contribute to overall cardiovascular risk assessment. J Am Soc Hypertens, 2 : 397-402.
White WB .2010 .The risk of wakingu‑p: Impact of the morning surge in blood pressure. Hypertension, 55 : 835-7.
Shore S,Aggarwal V,Zolty R .2012 .Carvedilol or sustainedr‑elease metoprolol for congestive heart failure: A comparative effectiveness analysis. J Card Fail, 18 : 9192-4.
Javaheri S. .2013 .Sleep in cardiovascular disease. Encyclopedia of Sleep, : 557-62.
Valle JA,Zhang M,Dixon S,Aronow HD,Share D,Naoum JB .2013 .Impact of pre‑procedural beta blockade on inpatient mortality in patients undergoing primar y percutaneous coronar y inter vention for ST elevation myocardial infarction. Am J Cardiol, 111 : 1714-20.
Hackam DG,Quinn RR,Ravani P,Rabi DM,Dasgupta K,Daskalopoulou SS .2013 .The 2013 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention, and treatment of hypertension. Can J Cardiol, 29 : 528-42.
Karlson BW,Dellborg M,Gullestad L,Aberg J,Sugg J,Herlitz J. .2014 .A pharmacokinetic and pharmacodynamic comparison of immediate‑release metoprolol and extended‑release metoprolol CR/XL in patients with suspected acute myocardial infarction: A randomized, open‑label study. Cardiology, 127 : 73-82.
Stranges PM,Drew AM,Rafferty P,Shuster JE,Brooks AD .2015 .Treatment of hypertension with chronotherapy: Is it time of drug administration?. Ann Pharmacother, 49 : 323-34.
Yilmaz B,Asci A,Arslan S. .2010 .Determination of metoprolol in human plasma and urine by high‑performance liquid chromatography with fluorescence detection. J Sep Sci, 33 : 1904-8.
Venkateswarlu P,Kumar BN,Seshaiah K,Prasad VV .2010 .Selective and sensitive method for the determination of metoprolol in human plasma using liquid chromatography coupled with tandem mass spectrometry. Acta Pharm, 60 : 177-84.
0

Citations

0

Downloads

12

Views